The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Evidence for the presence of five distinct proteolytic components in the pituitary multicatalytic proteinase complex. Properties of two components cleaving bonds on the carboxyl side of branched chain and small neutral amino acids
Abstract
Initial studies on the specificity of the multicatalytic proteinase complex (MPC; EC 3.4.99.46) led to the identification of three distinct proteolytic components designated as trypsin-like, chymotrypsin-like, and peptidylglutamyl-peptide hydrolyzing, all sensitive to inactivation by 3,4-dichloroisocoumarin (DCI), a general serine proteinase inhibitor. The three components cleave the peptidyl-arylamide bonds in the model synthetic substrates, Z-(D)-Ala-Leu-Arg-2-naphthylamide, Z-Gly-Gly-Leu-p-nitroanilide, and Z-Leu-Leu-Glu-2-naphthylamide, respectively. We report here evidence for the presence in the MPC of two additional distinct components, neither of them capable of cleaving the three model substrates. One of these components cleaves the Leu-Gly and the Leu-Ala bonds in the substrates Cbz-Gly-Pro-Ala-Leu-Gly-p-aminobenzoate and Cbz-Gly-Pro-Ala-Leu-Ala-p-aminobenzoate, respectively, and is activated by treatment of the MPC with DCI, N-ethylmaleimide, Mg2+, Ca2+, and low concentrations of sodium dodecyl sulfate and fatty acids. This component is apparently identical with the previously identified DCI-resistant component of the MPC that cleaves preferentially bonds on the carboxyl side of branched chain amino acids in natural peptides including neurotensin and proinsulin [Cardozo, C., Vinitsky, A., Hidalgo, M. C., Michaud, C., & Orlowski, M. (1992) Biochemistry 31, 7373-7380]. It is probably also identical with the component proposed to be the main factor responsible for the caseinolytic activity [Pereira, M. E., Nguyen, T., Wagner, B. J., Margolis, J. W., Yu, B., & Wilk, S. (1992a) J. Biol. Chem. 267, 7949-7955]. The designation "branched chain amino acid preferring" (BrAAP) is proposed for this component. The second component cleaves peptide bonds between the small neutral amino acids Ala-Gly and Gly-Gly in the substrates Cbz-Gly-Pro-Ala-Ala-Gly-p-aminobenzoate and Cbz-Gly-Pro-Ala-Gly-Gly-p-aminobenzoate, respectively. This component is sensitive to inactivation by DCI, N-ethylmaleimide, and organic mercurials, but unlike the BrAAP it is significantly activated neither by Mg2+ or Ca2+ nor by fatty acids or sodium dodecyl sulfate. The designation "small neutral amino acid preferring" (SNAAP) is proposed for this component. Both components are sensitive to inhibition by the peptidyl-aldehydes N-acetyl-Leu-Leu-norleucinal (Ac-LLnL-CHO; calpain inhibitor I) and N-acetyl-Leu-Leu-methioninal (Ac-LLM-CHO; calpain inhibitor II) but are resistant to inhibition by Z-LLF-CHO, a potent inhibitor of the chymotrypsin-like activity.(ABSTRACT TRUNCATED AT 400 WORDS)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A NEW COUPLING COMPONENT FOR SULFANILAMIDE DETERMINATION
Bratton, A. C., & Marshall, E. K. (1939) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)73708-3 · Cited by 2,908
Cyclin is degraded by the ubiquitin pathway
Glotzer, M., Murray, A. W., & Kirschner, M. W. (1991) · Nature · doi:10.1038/349132a0 · Cited by 2,357
Fluorescence reaction for amino acids
Roth, M. (1971) · Analytical Chemistry · doi:10.1021/ac60302a020 · Cited by 1,349
The Use of Esters of N-Hydroxysuccinimide in Peptide Synthesis
Anderson, G. W., Zimmerman, J. E., & Callahan, F. M. (1964) · Journal of the American Chemical Society · doi:10.1021/ja01063a037 · Cited by 1,240
Goldbarg, J. A., & Rutenburg, A. M. (1958) · Cancer · doi:10.1002/1097-0142(195803/04)11:2<283::aid-cncr2820110209>3.0.co;2-8 · Cited by 793
The multicatalytic proteinase complex, a major extralysosomal proteolytic system
Orlowski, M. (1990) · Biochemistry · doi:10.1021/bi00497a001 · Cited by 457
Self-citationGlynne, R., Powis, S. H., Beck, S., Kelly, A., Kerr, L.-A., & Trowsdale, J. (1991) · Nature · doi:10.1038/353357a0 · Cited by 423
Ubiquitin-Mediated Pathways for Intracellular Proteolysis
Rechsteiner, M. (1987) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.03.110187.000245 · Cited by 408
Eytan, E., Ganoth, D., Armon, T., & Hershko, A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.20.7751 · Cited by 365
Evidence that Pituitary Cation‐Sensitive Neutral Endopeptidase Is a Multicatalytic Protease Complex
Wilk, S., & Orlowski, M. (1983) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1983.tb08056.x · Cited by 358
Self-citation
Cited by
Crystal Structure of the 20 S Proteasome from the Archaeon T. acidophilum at 3.4 Å Resolution
Löwe, J., Stock, D., Jap, B., Zwickl, P., Baumeister, W., & Huber, R. (1995) · Science · doi:10.1126/science.7725097 · Cited by 1,525
The proteasome: a suitable antineoplastic target
Adams, J. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1361 · Cited by 1,201
Proteasome inhibitors: from research tools to drug candidates
Kisselev, A. F., & Goldberg, A. L. (2001) · Chemistry & Biology · doi:10.1016/s1074-5521(01)00056-4 · Cited by 1,184
Irreversible Inhibitors of Serine, Cysteine, and Threonine Proteases
Powers, J. C., Asgian, J. L., Ekici, Ö. D., & James, K. E. (2002) · Chemical Reviews · doi:10.1021/cr010182v · Cited by 1,090
MECHANISMS OF MHC CLASS I–RESTRICTED ANTIGEN PROCESSING
Pamer, E., & Cresswell, P. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.323 · Cited by 1,008
DEGRADATION OF CELL PROTEINS AND THE GENERATION OF MHC CLASS I-PRESENTED PEPTIDES
Rock, K. L., & Goldberg, A. L. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.739 · Cited by 921
Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity
Meng, L., Mohan, R., Kwok, B. H. B., Elofsson, M., Sin, N., & Crews, C. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.18.10403 · Cited by 920
Proteasome from Thermoplasma acidophilum : a Threonine Protease
Seemüller, E., Lupas, A., Stock, D., Löwe, J., Huber, R., & Baumeister, W. (1995) · Science · doi:10.1126/science.7725107 · Cited by 634
Heinemeyer, W., Fischer, M., Krimmer, T., Stachon, U., & Wolf, D. H. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.40.25200 · Cited by 519
The Structure of the Mammalian 20S Proteasome at 2.75 Å Resolution
Unno, M., Mizushima, T., Morimoto, Y., Tomisugi, Y., Tanaka, K., Yasuoka, N., & Tsukihara, T. (2002) · Structure · doi:10.1016/s0969-2126(02)00748-7 · Cited by 519
Huber, E. M., Basler, M., Schwab, R., Heinemeyer, W., Kirk, C. J., Groettrup, M., & Groll, M. (2012) · Cell · doi:10.1016/j.cell.2011.12.030 · Cited by 483
Activation of the cell death program by inhibition of proteasome function
Drexler, H. C. A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.3.855 · Cited by 481
Groll, M., Berkers, C. R., Ploegh, H. L., & Ovaa, H. (2006) · Structure · doi:10.1016/j.str.2005.11.019 · Cited by 473
Werner, E. D., Brodsky, J. L., & McCracken, A. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13797 · Cited by 462
The ubiquitin‐proteasome pathway and proteasome inhibitors
Myung, J., Kim, K. B., & Crews, C. M. (2001) · Medicinal Research Reviews · doi:10.1002/med.1009 · Cited by 446
Bochtler, M., Ditzel, L., Groll, M., Hartmann, C., & Huber, R. (1999) · Annual Review of Biophysics and Biomolecular Structure · doi:10.1146/annurev.biophys.28.1.295 · Cited by 435
20S Proteasome and Its Inhibitors: Crystallographic Knowledge for Drug Development
Borissenko, L., & Groll, M. (2007) · Chemical Reviews · doi:10.1021/cr0502504 · Cited by 407
Regular exercise improves cognitive function and decreases oxidative damage in rat brain
Radák, Z., Kaneko, T., Tahara, S., Nakamoto, H., Pucsok, J., Sasvári, M., Nyakas, C., & Goto, S. (2001) · Neurochemistry International · doi:10.1016/s0197-0186(00)00063-2 · Cited by 373
Proteasomes: destruction as a programme
Hilt, W., & Wolf, D. H. (1996) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(96)10012-8 · Cited by 368
Protein degradation and the generation of MHC class I-presented peptides
Rock, K. L., York, I. A., Saric, T., & Goldberg, A. L. (2002) · Advances in Immunology · doi:10.1016/s0065-2776(02)80012-8 · Cited by 339
The Mechanistic Links Between Proteasome Activity, Aging and Agerelated Diseases
Saez, I., & Vilchez, D. (2014) · Current Genomics · doi:10.2174/138920291501140306113344 · Cited by 325
Catalytic Activities of the 20 S Proteasome, a Multicatalytic Proteinase Complex
Orlowski, M., & Wilk, S. (2000) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2000.2036 · Cited by 308
Self-citationArendt, C. S., & Hochstrasser, M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.14.7156 · Cited by 302
Impairment of proteasome structure and function in aging
Carrard, G., Bulteau, A.-L., Petropoulos, I., & Friguet, B. (2002) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(02)00085-7 · Cited by 301
Hughes, E. A., Hammond, C., & Cresswell, P. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.5.1896 · Cited by 299
Regulation of Protein Degradation.
Callis, J. (1995) · The Plant Cell · doi:10.1105/tpc.7.7.845 · Cited by 284
Radák, Z., Kaneko, T., Tahara, S., Nakamoto, H., Ohno, H., Sasvári, M., Nyakas, C., & Goto, S. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00038-6 · Cited by 277
Protein oxidation and cellular homeostasis: Emphasis on metabolism
Cecarini, V., Gee, J., Fioretti, E., Amici, M., Angeletti, M., Eleuteri, A. M., & Keller, J. N. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.08.039 · Cited by 274
The proteasome activator 11 S REG (PA28) and Class I antigen presentation
RECHSTEINER, M., REALINI, C., & USTRELL, V. (2000) · Biochemical Journal · doi:10.1042/bj3450001 · Cited by 265
Schubert, U., Antón, L. C., Bačík, I., Cox, J. H., Bour, S., Bennink, J. R., Orlowski, M., Strebel, K., & Yewdell, J. W. (1998) · Journal of Virology · doi:10.1128/jvi.72.3.2280-2288.1998 · Cited by 261
Self-citationDick, T. P., Nussbaum, A. K., Deeg, M., Heinemeyer, W., Groll, M., Schirle, M., Keilholz, W., Stevanović, S., Wolf, D. H., Huber, R., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.40.25637 · Cited by 260
Age-related changes in the 20S and 26S proteasome activities in the liver of male F344 rats.
Hayashi, T., & Goto, S. (1998) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(98)00011-6 · Cited by 125
Metadata
- Authors
- Orlowski, M., Cardozo, C., & Michaud, C.
- Venue
- Biochemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 1993-02-01
- Volume
- 32
- Issue
- 6
- Pages
- 1563-1572
- ISSN
- 0006-2960 (ISSN-L)
- 1520-4995
- OpenAlex
- W2072965202
- Cited by
- 321
- References
- 40
- FWCI
- 6.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.